pharma · Uveal Melanoma · HLA-A2 negative metastatic uveal melanoma · IDYA
IDEAYA Biosciences
IDEAYA Biosciences clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
5000 Shoreline Ct, Suite 300, South San Francisco, California 94080, US HQ
2015 Founded
248 Employees
Public company Type
IDYA · NYSE Ticker
Company details
- Status
- Public
- HQ
- 5000 Shoreline Ct, Suite 300, South San Francisco, California 94080, US
- Founded
- 2015
- Employees
- 248
- Programs
- 14
- Drugs
- 12
- Patents
- 12
IDEAYA Biosciences projects
0 ClinicalTrials.gov programs sponsored by IDEAYA Biosciences.
IDEAYA Biosciences has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
No programs matched
Frequently asked questions
How many clinical projects does IDEAYA Biosciences have?
0 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.